hIL3/hCSF2

Nomenclature

C57BL/6Smoc-Il3tm3(hIL3)Csf2tm3(hCSF2)/Smoc

Cat. NO.

NM-HU-190065

Strain State

Embryo cryopreservation

Export PDF

Model Description

The endogenous mouse Il3 and Csf2 gene was replaced by human IL3 and CSF2 gene.
Research Application：Immunotherapy,cancer research,drug screening

Validation Data

image.png

Fig.1 Detection of mCSF2(A) and hCSF2(B) expression in serum by ELISA(n=3). 

Abbr. HO, homozygous; WT, wild type; N.D. not detected

Note.hIL3/hCSF2 and C57BL/6 mice were i.p. injected with LPS for 2h.

image.png

Fig.2 Detection of mIL3(A) and hIL3(B) expression in splenocyte by ELISA(n=3). 

Abbr. HO, homozygous; WT, wild type; N.D. not detected.

Note. Splenocyte were stimulated with ConA and IL2 in vitro for 48h.


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more